# Evaluating Efficacy and Safety of CBD TPM Capsules for Use in Insomnia

> **NCT05840822** · PHASE3 · RECRUITING · sponsor: **Avecho Biotechnology** · enrollment: 519 (estimated)

## Conditions studied

- Insomnia

## Interventions

- **DRUG:** Cannabidiol (CBD) Capsule 75mg
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT05840822
- **Lead sponsor:** Avecho Biotechnology
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-05-16
- **Primary completion:** 2025-12
- **Final completion:** 2026-02
- **Target enrollment:** 519 (ESTIMATED)
- **Last updated:** 2025-06-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05840822

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05840822, "Evaluating Efficacy and Safety of CBD TPM Capsules for Use in Insomnia". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT05840822. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*